COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
06.10.20
COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce a number of initiatives that are bringing enhanced understanding of COVID-19 in near real-time. Leveraging its past knowledge of real-world evidence applications and learnings, COTA has joined the COVID-19 Evidence Accelerator program, a joint initiative of Friends of Cancer Research (Friends) and the Reagan-Udall Foundation for the Food and Drug Administration. Through this initiative, COTA is delivering findings from its observational, real-world studies using data from over 3,000 patients hospitalized with COVID-19 within the Hackensack Meridian Health network. Read Full Release
2020 MedTech Breakthrough Awards Recognize COTA as the Best Overall Medical Data Solution Provider
05.18.20
Boston, MA – May 18, 2020 – COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is pleased to announce that MedTech Breakthrough has named COTA as a winner in the fourth annual MedTech Breakthrough Awards program for the “Best Overall Medical Data Solution Provider" award. The MedTech Breakthrough Awards recognize the top companies, people, platforms, and products in various industries including health, fitness, and medi Read Full Release
BC Platforms and Kaiser Permanente Win 2020 Microsoft Health Innovation Award for Precision Medicine Collaboration
05.19.20
BC Platforms and Kaiser Permanente today announced they are winners of the 2020 Microsoft Health Innovation Award in the Reimagine Health Category for enabling a unique way of pairing clinical and genomic data on the same platform to advance precision medicine capabilities. Read Full Release
Reveleer COVID-19 Business Continuity Update
04.01.20
Dear friends, As the world continues to rapidly change around us due to Coronavirus (COVID-19), we wanted to reach out to our partners, and prospective partners, to let you know what to expect from Reveleer during this challenging time.First and foremost, our thoughts go out to those who have been directly impacted by COVID-19 and those working on the front lines to treat and control the spread of illness.... Read Full Release
Introducing the BBJ’s Fast 50, The Region’s Fastest Growing Companies
04.08.20
The BosBizJournal has recognized COTA on its 2020 Fast 50 list! We are proud to be one of the fastest-growing private companies in MA this year & are committed to continuing on this path as we transform #cancer care. Congrats to all companies. https://bit.ly/2Xi1IlI #BBJFAST50 Read Full Release
Forefront Telecare Launches Phase 2 of COVID-19 Response for Rural Hospitals
04.09.20
NASHVILLE, Tenn., April 9, 2020 (Newswire.com) - Forefront Telecare, Inc. (Forefront), the leader in providing behavioral telehealth to seniors and other vulnerable adults in rural communities across the United States, announced today the next phase of its #RuralHealthSTRONG COVID-19 Response Program. As part of this program, Forefront is offering behavioral telehealth carts with secure, HIPAA-compliant video conferencing at no-cost to hundreds of rural hospitals nationwide. This proven platform has already been deployed by Forefront to over 200 facilities across the country. Read Full Release
MedAptus Again Leads KLAS Mobile Charge Capture Rankings
02.04.20
The annual "Best in KLAS" report is out and for the tenth time since 2011, medaptus has earned a top ranking, this year in the Mobile Charge Capture category. The "2020 Best in KLAS Awards: Software & Services" names the top-performing healthcare IT and services companies based on customer feedback obtained in 2019. This latest award recognizes the performance of medaptus' charge capture technology which enables efficient, accurate, and complete coding and billing. Beyond the software's ability to "capture" a charge, a robust rules engine and interface gateway enable real-time charge management and reconciliation activities, regardless of charge source. This unique automation replaces manual processes with intelligence such as work queues that route charge data based on exception. This approach expedites the billing cycle and with less administrative effort.  Read Full Release
Reveleer
Boston Millennia Partners Leads Investment in Reveleer, Inc.
01.21.19
Boston Millennia Partners IV is pleased to announce its investment in Reveleer, Inc. as part of a growth equity financing round. Reveleer is a healthcare software and services company that empowers health insurance companies to take control of their risk adjustment and quality improvement programs. The Reveleer software platform enables insurers to independently execute and manage every aspect of provider outreach, health record retrieval, coding, abstraction, and reporting. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also provides record retrieval and review services to support financial performance and improved member outcomes. As value-based contracts expand and the Medicare Advantage population continues to grow, the company is well positioned to be a leader in risk adjustment and quality analysis software. Click below to read on. Read Full Release
Boston Millennia Partners
TUCK STUDENTS “VENTURE” TO BOSTON
12.10.19
Thanks to the initiative of Center for Private Equity and Venture Capital Executive Director, Jim Feuille D’79, who called everyone to attention from the dining booth seat, Brodie Stone T’20 and Ross Klosterman T’20 pitched their company, UnifiHealth, which is focusing on reimagining health benefits for small businesses. After an evening of socializing, we had a full Friday of scheduled stops at Bain Capital Ventures, Boston Millennia Partners, Charles River Ventures, Openview Venture Partners, Flare Capital, and Green D Ventures. Read Full Release
COTA Genomic Profiling Study Released
12.11.19
A retrospective review of the COTA Real World Data (RWD) database was performed to identify patients with pathologically confirmed metastatic colon cancer (mCC) diagnosed between January 1, 2013 and December 1, 2017. Although guidelines recommend molecular testing for patients with mCRC, the current study included patients with mCC and excluded rectal cancer cases. At the time of data extraction, the COTA database included demographic, diagnostic, treatment, and quality-of-care information for patients with colon cancer abstracted from the electronic health records from 23 practices including 258 oncologists in Arkansas, Maryland, Michigan, New Jersey, New York, and Tennessee who contribute data under Business Associate Agreements. All data were de-identified to be compliant with Health Insurance Portability and Accountability Act and Office of Health Promotion Research regulations for purposes of secondary research use. The structure of the COTA database has been reviewed by the Western Institutional Review Board and has been deemed exempt from patient informed consent. Read Full Release
Boston Millennia Partners
COTA Welcomes Daniel Lane as Vice President for HEOR to Drive Outcomes-Based Research in Oncology
07.25.19
COTA, Inc., a leading precision medicine technology company that uses real-world data to bring clarity to cancer care, has named Daniel Lane as its new Vice President for Health Economics and Outcomes Research (HEOR). Daniel brings extensive experience in leading oncology outcomes research organizations, and leveraging innovative datasets to generate impactful real world evidence (RWE) across multiple healthcare sectors. Combining this with COTA’s expertise and understanding of real-world data will allow the company to better support its partners as they improve access and quality in healthcare. Read Full Release
COTA
COTA, Inc. Announces Headquarter Relocation to Boston for Continued Growth
08.01.19
COTA, Inc., a healthcare technology company that uses real-world evidence to bring clarity to cancer care, has announced that the Company’s headquarters will be relocating to Boston on August 1, 2019. The Company will maintain a New York City presence, but will continue to grow and reinforce its operational activities in Boston. Boston’s robust health technology and life science industries fit perfectly with COTA’s mission of improving cancer care. The Company will be located at 101 Arch Street Read Full Release
FDA Leverages Private Sector Technology-Based Tools In Its Embrace Of Real World Evidence
07.09.19
The agency has signaled its apparent change of heart with speeches, policy guidance, and now with two public-private partnerships: the recent expansion of its agreement with Flatiron Health, and a brand new collaboration with COTA Healthcare. The Flatiron collaboration initially focused on patients being treated with immunotherapy for advanced non-small cell lung cancer; the new work concerns “the use of RWE in regulatory decision-making, including characterization of data quality, validation of reliable real-world clinical endpoints, collaboration on new analytic methodologies, and exploration of innovative applications such as real-world control arms.” The COTA collaboration will focus on breast cancer patients and treatment options. Read Full Release
Boston Millennia Partners
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read Full Release
COTA Signs Research Collaboration Agreement With The U.S. Food and Drug Administration
05.29.19
COTA, Inc., a leading precision medicine technology company that uses real-world evidence to bring clarity to cancer care, today announced it has signed a two-year Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) Information Exchange and Data Transformation (INFORMED) Program, the Agency's data science and technology incubator supporting regulatory science research. This RCA will establish a study protocol with an initial focus on breast cancer, and will provide the FDA with information on the evolving treatment landscape, including insight on treatment variation within defined subpopulations of patients with the disease. As the project advances, the research may expand to other cancer types and explore disease characteristics, treatment patterns, and patient outcomes for the broader application of precision medicine. Read Full Release
COTA to attend ASCO May 31st – June 4th, 2019
05.31.19
Attending #ASCO19 5/31-6/4? Stop by Booth #2063 to learn how COTA organizes fragmented, often hidden data from the real world to provide a clear view of cancer or schedule a demo with us here: meetus@cotahealthcare.comFind more details about the attending here. Read Full Release
Forefront Telecare, Behavioral Health Solution for Rural Americans, Completes $15 Million Growth Equity Funding Round
04.24.19
Boston, MA, April 2019 Boston Millennia Partners IV is pleased to announce its investment in Forefront Telecare, Inc. as part of a $15 million growth equity round. Forefront is a leading provider of behavioral services via Telehealth to vulnerable populations across the country. With a focus on high acuity psychiatric patients in rural markets, Forefront offers services to hospitals, skilled nursing facilities, and clinics that have limited access to behavioral health practitioners. The solution consists of an extensive provider network, a modern video conferencing platform, and scalable in-house billing. The company currently serves over 175 customers and will be relocating headquarters to New Jersey. Read Full Release
Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations
03.31.19
Health Decisions, Inc., the full-service clinical research organization (CRO) of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, has appointed Sheila Kiss as Head of European Clinical Operations. With more than 35 years’ experience in Clinical Operations and Project Management, Kiss will support Health Decisions’ dedicated Clinical Operations Team to execute research in Women’s Health and In Vitro Diagnostic clinical development. Read Full Release
MEDAPTUS NAMES DR. SUSAN KATZ SLISKI AS CHIEF NURSING OFFICER
02.05.19
Susan Katz Sliski, DNP, RN, CCM, FAAOHN has been named the Chief Nursing Officer (CNO) for MedAptus, Inc. In her role, Dr. Katz Sliski will be working closely with the product management team to promote and improve all MedAptus products, with a special focus on ASSIGN for Nurses, the company’s flagship patient assignment software for nurses. In her most recent role prior to joining MedAptus, Dr. Katz Sliski was leading REDESIGN initiatives within healthcare organizations to improve patient and provider experiences, drive organizational effectiveness and decrease costs. Read Full Release
MedAptus
MEDAPTUS RANKED #1 IN KLAS RANKINGS FOR MOBILE CHARGE CAPTURE IN 2019
01.31.19
“This is one more indication of our commitment towards providing the very best charge management solutions in healthcare,” said Eugene Schneider, MedAptus president and CEO. “Whether it’s for professionals, facilities or even infusion coding services, our charge capture, management and reconciliation processes are consistently finding new sources of revenue for our customers. That’s extremely important as hospitals and other entities continue to tighten belts in this very challenging healthcare environment.” Read Full Release